thank
leow
correspond
recogn
signific
recent
work
also
welcom
construct
comment
provid
concern
limit
studi
studi
focus
vitro
cell
line
suscept
novel
coronaviru
renam
middl
east
respiratori
syndrom
coronaviru
merscov
agre
leow
result
studi
vitro
cell
line
tropism
may
directli
correl
vivo
behavior
viru
observ
merscov
replic
effici
sarscov
within
vitro
human
tissu
support
find
subsequ
ex
vivo
cultur
system
show
merscov
product
replic
human
bronchial
lung
tissu
compar
sever
acut
respiratori
syndrom
sar
cov
replic
lung
tissu
furthermor
anim
model
use
rhesu
macaqu
merscov
infect
recent
develop
show
histopatholog
evid
acut
local
widespread
lung
consolid
infect
anim
result
clinic
diseas
detail
histopatholog
examin
patient
merscov
infect
would
import
confirm
chang
human
although
dysfunct
axi
well
describ
patient
merscov
patient
develop
hyponatremia
possibl
relat
syndrom
inappropri
antidiuret
hormon
secret
agre
studi
predilect
viru
endocrin
tissu
might
import
understand
pathogenesi
highli
fatal
diseas
optim
treatment
strategi
particular
therapeut
role
potenti
detriment
effect
system
corticosteroid
use
empir
earli
diseas
stage
patient
merscov
infect
remain
unclear
sinc
public
articl
merscov
epidem
continu
evolv
without
obviou
sign
complet
control
total
number
laboratoryconfirm
case
countri
contin
increas
fatal
juli
although
anim
reservoir
merscov
suggest
definit
sourc
far
identifi
epidemiolog
emerg
post
evolv
outbreak
also
call
develop
effect
antivir
treatment
addit
support
treatment
extracorpor
membran
oxygen
renal
replac
therapi
combin
ribavirin
recent
shown
exhibit
vitro
antimerscov
activ
efficaci
potenti
therapeut
strategi
includ
interferon
antivir
peptid
target
heptad
repeat
region
merscov
spike
protein
domaindipeptidyl
peptidas
interfac
inhibitor
determin
laboratori
clinic
studi
